A compound of Formula or a stereoisomeric form thereof, wherein R is selected from the group of hydrogen; halo; -CN; C 1-4 alkyl optionally substituted with one or more substituents each independently selected from halo, -CN and C 1-4 alkyloxy; C 1-4 alkyloxy optionally substituted with one or more substituents each independently selected from halo and C 1-4 alkyloxy; and -(CH 2) m -NR x C=O)R y, wherein m is an integer selected from the group of 0, 1, 2, and 3, R x is selected from H and C 1-4 alkyl, and R y is C 1-4 alkyl; R 1 is selected from the group of hydrogen; halo; C 1-4 alkyl optionally substituted with one or more halo substituents; -C 1-4 alkyl(C 3-7 cycloalkyl); and C 3-7 cycloalkyl; R 2 is selected from the group of C 1-4 alkyl optionally substituted with one or more substituents each independently selected from fluoro, and C 1-4 alkyloxy; and C 3-7 cycloalkyl; R 3 is in each instance an independently selected halo substituent; n is an integer selected from 1 and 2; R 4 is selected from (a) and (b): (a) (b) wherein R 5 and R 6 are each independently selected from the group of aryl and heteroaryl, each of which may be optionally substituted with one or more substituents each independently selected from the group of halo, -CN, C 1-4 alkyl optionally substituted with one or more halo substituents, and C 1-4 alkyloxy optionally substituted with one or more halo substituents; wherein aryl is phenyl; wherein heteroaryl is a 5-membered aromatic heterocycle selected from the group consisting of oxazole and pyrazole; or is a 6-membered aromatic heterocycle selected from the group consisting of pyridinyl, pyrimidinyl and pyrazinyl; or a pharmaceutically acceptable addition salt or a solvate thereof. R is selected from the group of hydrogen; halo; -CN; C 1-4 alkyl optionally substituted with one or more substituents each independently selected from halo, -CN and C 1-4 alkyloxy; C 1-4 alkyloxy optionally substituted with one or more substituents each independently selected from halo and C 1-4 alkyloxy; and -(CH 2) m -NR x C=O)R y, wherein m is an integer selected from the group of 0, 1, 2, and 3, R x is selected from H and C 1-4 alkyl, and R y is C 1-4 alkyl; R 1 is selected from the group of hydrogen; halo; C 1-4 alkyl optionally substituted with one or more halo substituents; -C 1-4 alkyl(C 3-7 cycloalkyl); and C 3-7 cycloalkyl; R 2 is selected from the group of C 1-4 alkyl optionally substituted with one or more substituents each independently selected from fluoro, and C 1-4 alkyloxy; and C 3-7 cycloalkyl; R 3 is in each instance an independently selected halo substituent; n is an integer selected from 1 and 2; R 4 is selected from (a) and (b): (a) (b) (a) (b) wherein R 5 and R 6 are each independently selected from the group of aryl and heteroaryl, each of which may be optionally substituted with one or more substituents each independently selected from the group of halo, -CN, C 1-4 alkyl optionally substituted with one or more halo substituents, and C 1-4 alkyloxy optionally substituted with one or more halo substituents; wherein aryl is phenyl; wherein heteroaryl is a 5-membered aromatic heterocycle selected from the group consisting of oxazole and pyrazole; or is a 6-membered aromatic heterocycle selected from the group consisting of pyridinyl, pyrimidinyl and pyrazinyl; or a pharmaceutically acceptable addition salt or a solvate thereof.